Content deleted Content added
No edit summary |
|||
Line 193:
[[Radiation therapy]] for prostate cancer was first developed in the early 20th century and initially consisted of intraprostatic [[radium]] implants. External beam radiation became more popular as stronger radiation sources became available in the middle of the 20th century. Brachytherapy with implanted seeds was first described in 1983.<ref>Denmeade SR, Isaacs JT. ''A History of Prostate Cancer Treatment.'' Nature Reviews Cancer 2, 389–396 (2002). PMID 12044015</ref> Systemic chemotherapy for prostate cancer was first studied in the 1970s. The initial regimen of [[cyclophosphamide]] and [[5-fluorouracil]] was quickly joined by multiple regimens using a host of other systemic chemotherapy drugs.<ref>Scott, W. W. et al. ''Chemotherapy of advanced prostatic carcinoma with cyclophosphamide or 5-fluorouracil: results of first national randomized study.'' J. Urol. 114, 909–911 (1975). PMID 1104900</ref>
==Miscellaneous Facts==
* Men were less likely to be hospitalized for prostate cancer treatment in 2004 than in 1997, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. Hospitalizations for treatment of the disease fell nearly 30 percent in those eight years. Prostate cancer is the second-most common cancer in men. For more information - [http://prostatenews.info/article/Prostate-Cancer-Treatment/1/Yahoo/ ProstateNews.info]
==References==
| |||